APA (7th ed.) Citation

Leonard, C. E., Brensinger, C. M., Dawwas, G. K., Deo, R., Bilker, W. B., Soprano, S. E., . . . Hennessy, S. (2020). The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: Real-world evidence on thiazolidinedione safety. Cardiovascular Diabetology, 19(1), 1. https://doi.org/10.1186/s12933-020-00999-5

Chicago Style (17th ed.) Citation

Leonard, Charles E., et al. "The Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia with Rosiglitazone Versus Pioglitazone: Real-world Evidence on Thiazolidinedione Safety." Cardiovascular Diabetology 19, no. 1 (2020): 1. https://doi.org/10.1186/s12933-020-00999-5.

MLA (9th ed.) Citation

Leonard, Charles E., et al. "The Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia with Rosiglitazone Versus Pioglitazone: Real-world Evidence on Thiazolidinedione Safety." Cardiovascular Diabetology, vol. 19, no. 1, 2020, p. 1, https://doi.org/10.1186/s12933-020-00999-5.